Report Detail
COVID-19 Impact on Global Drug-Coated Balloons Market Insights, Forecast to 2026
- RnM4070136 |
- 19 June, 2020 |
- Global |
- 150 Pages |
- QYResearch |
- Medical Devices & Consumables
Drug-Coated Balloons market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug-Coated Balloons market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Drug-Coated Balloons market is segmented into
DCB for Peripheral Artery Disease
DCB for Coronary Artery Disease
DCB for Other Indications
Segment by Application, the Drug-Coated Balloons market is segmented into
Hospitals
Cardiac Catheterization Labs
ASCs
Regional and Country-level Analysis
The Drug-Coated Balloons market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug-Coated Balloons market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Drug-Coated Balloons Market Share Analysis
Drug-Coated Balloons market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Drug-Coated Balloons by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Drug-Coated Balloons business, the date to enter into the Drug-Coated Balloons market, Drug-Coated Balloons product introduction, recent developments, etc.
The major vendors covered:
Medtronic
BD
B. Braun Melsungen
Koninklijke Philips
Boston Scientific
Opto Circuits (India)
Acotec Scientific
AR Baltic Medical
Acrostak
Biosensors International Group
BioMed
Concept Medical
Cardionovum
Endocor
Hexacath Sverige
iVascular SLU
Minvasys
MedAlliance
QT Vascular
RD Global-Invamed
SurModics
Terumo
1 Study Coverage
- 1.1 Drug-Coated Balloons Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Drug-Coated Balloons Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Drug-Coated Balloons Market Size Growth Rate by Type
- 1.4.2 DCB for Peripheral Artery Disease
- 1.4.3 DCB for Coronary Artery Disease
- 1.4.4 DCB for Other Indications
- 1.5 Market by Application
- 1.5.1 Global Drug-Coated Balloons Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Cardiac Catheterization Labs
- 1.5.4 ASCs
- 1.6 Coronavirus Disease 2019 (Covid-19): Drug-Coated Balloons Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Drug-Coated Balloons Industry
- 1.6.1.1 Drug-Coated Balloons Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Drug-Coated Balloons Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Drug-Coated Balloons Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Drug-Coated Balloons Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Drug-Coated Balloons Market Size Estimates and Forecasts
- 2.1.1 Global Drug-Coated Balloons Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Drug-Coated Balloons Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Drug-Coated Balloons Production Estimates and Forecasts 2015-2026
- 2.2 Global Drug-Coated Balloons Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Drug-Coated Balloons Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Drug-Coated Balloons Manufacturers Geographical Distribution
- 2.4 Key Trends for Drug-Coated Balloons Markets & Products
- 2.5 Primary Interviews with Key Drug-Coated Balloons Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Drug-Coated Balloons Manufacturers by Production Capacity
- 3.1.1 Global Top Drug-Coated Balloons Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Drug-Coated Balloons Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Drug-Coated Balloons Manufacturers Market Share by Production
- 3.2 Global Top Drug-Coated Balloons Manufacturers by Revenue
- 3.2.1 Global Top Drug-Coated Balloons Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Drug-Coated Balloons Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Drug-Coated Balloons Revenue in 2019
- 3.3 Global Drug-Coated Balloons Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Drug-Coated Balloons Production by Regions
- 4.1 Global Drug-Coated Balloons Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Drug-Coated Balloons Regions by Production (2015-2020)
- 4.1.2 Global Top Drug-Coated Balloons Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Drug-Coated Balloons Production (2015-2020)
- 4.2.2 North America Drug-Coated Balloons Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Drug-Coated Balloons Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Drug-Coated Balloons Production (2015-2020)
- 4.3.2 Europe Drug-Coated Balloons Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Drug-Coated Balloons Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Drug-Coated Balloons Production (2015-2020)
- 4.4.2 China Drug-Coated Balloons Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Drug-Coated Balloons Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Drug-Coated Balloons Production (2015-2020)
- 4.5.2 Japan Drug-Coated Balloons Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Drug-Coated Balloons Import & Export (2015-2020)
5 Drug-Coated Balloons Consumption by Region
- 5.1 Global Top Drug-Coated Balloons Regions by Consumption
- 5.1.1 Global Top Drug-Coated Balloons Regions by Consumption (2015-2020)
- 5.1.2 Global Top Drug-Coated Balloons Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Drug-Coated Balloons Consumption by Application
- 5.2.2 North America Drug-Coated Balloons Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Drug-Coated Balloons Consumption by Application
- 5.3.2 Europe Drug-Coated Balloons Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Drug-Coated Balloons Consumption by Application
- 5.4.2 Asia Pacific Drug-Coated Balloons Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Drug-Coated Balloons Consumption by Application
- 5.5.2 Central & South America Drug-Coated Balloons Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Drug-Coated Balloons Consumption by Application
- 5.6.2 Middle East and Africa Drug-Coated Balloons Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Drug-Coated Balloons Market Size by Type (2015-2020)
- 6.1.1 Global Drug-Coated Balloons Production by Type (2015-2020)
- 6.1.2 Global Drug-Coated Balloons Revenue by Type (2015-2020)
- 6.1.3 Drug-Coated Balloons Price by Type (2015-2020)
- 6.2 Global Drug-Coated Balloons Market Forecast by Type (2021-2026)
- 6.2.1 Global Drug-Coated Balloons Production Forecast by Type (2021-2026)
- 6.2.2 Global Drug-Coated Balloons Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Drug-Coated Balloons Price Forecast by Type (2021-2026)
- 6.3 Global Drug-Coated Balloons Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Drug-Coated Balloons Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Drug-Coated Balloons Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 Medtronic
- 8.1.1 Medtronic Corporation Information
- 8.1.2 Medtronic Overview and Its Total Revenue
- 8.1.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 Medtronic Product Description
- 8.1.5 Medtronic Recent Development
- 8.2 BD
- 8.2.1 BD Corporation Information
- 8.2.2 BD Overview and Its Total Revenue
- 8.2.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 BD Product Description
- 8.2.5 BD Recent Development
- 8.3 B. Braun Melsungen
- 8.3.1 B. Braun Melsungen Corporation Information
- 8.3.2 B. Braun Melsungen Overview and Its Total Revenue
- 8.3.3 B. Braun Melsungen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 B. Braun Melsungen Product Description
- 8.3.5 B. Braun Melsungen Recent Development
- 8.4 Koninklijke Philips
- 8.4.1 Koninklijke Philips Corporation Information
- 8.4.2 Koninklijke Philips Overview and Its Total Revenue
- 8.4.3 Koninklijke Philips Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 Koninklijke Philips Product Description
- 8.4.5 Koninklijke Philips Recent Development
- 8.5 Boston Scientific
- 8.5.1 Boston Scientific Corporation Information
- 8.5.2 Boston Scientific Overview and Its Total Revenue
- 8.5.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Boston Scientific Product Description
- 8.5.5 Boston Scientific Recent Development
- 8.6 Opto Circuits (India)
- 8.6.1 Opto Circuits (India) Corporation Information
- 8.6.2 Opto Circuits (India) Overview and Its Total Revenue
- 8.6.3 Opto Circuits (India) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 Opto Circuits (India) Product Description
- 8.6.5 Opto Circuits (India) Recent Development
- 8.7 Acotec Scientific
- 8.7.1 Acotec Scientific Corporation Information
- 8.7.2 Acotec Scientific Overview and Its Total Revenue
- 8.7.3 Acotec Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Acotec Scientific Product Description
- 8.7.5 Acotec Scientific Recent Development
- 8.8 AR Baltic Medical
- 8.8.1 AR Baltic Medical Corporation Information
- 8.8.2 AR Baltic Medical Overview and Its Total Revenue
- 8.8.3 AR Baltic Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 AR Baltic Medical Product Description
- 8.8.5 AR Baltic Medical Recent Development
- 8.9 Acrostak
- 8.9.1 Acrostak Corporation Information
- 8.9.2 Acrostak Overview and Its Total Revenue
- 8.9.3 Acrostak Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 Acrostak Product Description
- 8.9.5 Acrostak Recent Development
- 8.10 Biosensors International Group
- 8.10.1 Biosensors International Group Corporation Information
- 8.10.2 Biosensors International Group Overview and Its Total Revenue
- 8.10.3 Biosensors International Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 Biosensors International Group Product Description
- 8.10.5 Biosensors International Group Recent Development
- 8.11 BioMed
- 8.11.1 BioMed Corporation Information
- 8.11.2 BioMed Overview and Its Total Revenue
- 8.11.3 BioMed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.11.4 BioMed Product Description
- 8.11.5 BioMed Recent Development
- 8.12 Concept Medical
- 8.12.1 Concept Medical Corporation Information
- 8.12.2 Concept Medical Overview and Its Total Revenue
- 8.12.3 Concept Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.12.4 Concept Medical Product Description
- 8.12.5 Concept Medical Recent Development
- 8.13 Cardionovum
- 8.13.1 Cardionovum Corporation Information
- 8.13.2 Cardionovum Overview and Its Total Revenue
- 8.13.3 Cardionovum Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.13.4 Cardionovum Product Description
- 8.13.5 Cardionovum Recent Development
- 8.14 Endocor
- 8.14.1 Endocor Corporation Information
- 8.14.2 Endocor Overview and Its Total Revenue
- 8.14.3 Endocor Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.14.4 Endocor Product Description
- 8.14.5 Endocor Recent Development
- 8.15 Hexacath Sverige
- 8.15.1 Hexacath Sverige Corporation Information
- 8.15.2 Hexacath Sverige Overview and Its Total Revenue
- 8.15.3 Hexacath Sverige Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.15.4 Hexacath Sverige Product Description
- 8.15.5 Hexacath Sverige Recent Development
- 8.16 iVascular SLU
- 8.16.1 iVascular SLU Corporation Information
- 8.16.2 iVascular SLU Overview and Its Total Revenue
- 8.16.3 iVascular SLU Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.16.4 iVascular SLU Product Description
- 8.16.5 iVascular SLU Recent Development
- 8.17 Minvasys
- 8.17.1 Minvasys Corporation Information
- 8.17.2 Minvasys Overview and Its Total Revenue
- 8.17.3 Minvasys Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.17.4 Minvasys Product Description
- 8.17.5 Minvasys Recent Development
- 8.18 MedAlliance
- 8.18.1 MedAlliance Corporation Information
- 8.18.2 MedAlliance Overview and Its Total Revenue
- 8.18.3 MedAlliance Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.18.4 MedAlliance Product Description
- 8.18.5 MedAlliance Recent Development
- 8.19 QT Vascular
- 8.19.1 QT Vascular Corporation Information
- 8.19.2 QT Vascular Overview and Its Total Revenue
- 8.19.3 QT Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.19.4 QT Vascular Product Description
- 8.19.5 QT Vascular Recent Development
- 8.20 RD Global-Invamed
- 8.20.1 RD Global-Invamed Corporation Information
- 8.20.2 RD Global-Invamed Overview and Its Total Revenue
- 8.20.3 RD Global-Invamed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.20.4 RD Global-Invamed Product Description
- 8.20.5 RD Global-Invamed Recent Development
- 8.21 SurModics
- 8.21.1 SurModics Corporation Information
- 8.21.2 SurModics Overview and Its Total Revenue
- 8.21.3 SurModics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.21.4 SurModics Product Description
- 8.21.5 SurModics Recent Development
- 8.22 Terumo
- 8.22.1 Terumo Corporation Information
- 8.22.2 Terumo Overview and Its Total Revenue
- 8.22.3 Terumo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.22.4 Terumo Product Description
- 8.22.5 Terumo Recent Development
- 8.23 Wellinq
- 8.23.1 Wellinq Corporation Information
- 8.23.2 Wellinq Overview and Its Total Revenue
- 8.23.3 Wellinq Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.23.4 Wellinq Product Description
- 8.23.5 Wellinq Recent Development
9 Production Forecasts by Regions
- 9.1 Global Top Drug-Coated Balloons Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Drug-Coated Balloons Regions Forecast by Production (2021-2026)
- 9.3 Key Drug-Coated Balloons Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Drug-Coated Balloons Consumption Forecast by Region
- 10.1 Global Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
- 10.2 North America Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
- 10.3 Europe Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Drug-Coated Balloons Sales Channels
- 11.2.2 Drug-Coated Balloons Distributors
- 11.3 Drug-Coated Balloons Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Market Opportunities and Drivers
- 12.2 Market Challenges
- 12.3 Market Risks/Restraints
- 12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Drug-Coated Balloons Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Drug-Coated Balloons. Industry analysis & Market Report on COVID-19 Impact on Global Drug-Coated Balloons is a syndicated market report, published as COVID-19 Impact on Global Drug-Coated Balloons Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Drug-Coated Balloons market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
